Sorted By:


Lung-MAP Demonstrates Real Change in Cancer Research and Care Possible through Collaboration

PhRMA  |  Blog Post

This month, the Lung-MAP (Lung Cancer Master Protocol) trial for squamous cell lung cancer has expanded to over 400 locations, offering patients across the country access to promising therapies for a historically undertreated form of lung cancer.

Nearly 200 New Medicines in Development for Diabetes

PhRMA  |  Press Release

(February 11, 2014) — America’s biopharmaceutical research companies currently are developing 180 innovative new medicines to help the nearly 400 million people who have diabetes worldwide.

PhRMA Statement Regarding Benefits of New Medicines

PhRMA  |  Press Release

Wheadon issued the following statement today regarding the benefits that new medicines provide to patients and public health: “The Food and Drug Administration (FDA) has approved more than 300 new medicines in the past decade, helping patients to live longer, healthier and more productive lives.

TPP's Outcome Pivotal For Future Of Global Biomedical Innovation

From Hope To Cures  |  From Our Network

(And biologics such as Avastin and Herceptin account for the overwhelming majority of the most effective anti-cancer drugs, with more than 300 anti-cancer biologics currently under development.)

She Has Health Insurance, But Can't Pay Her Medical Bills. She's Not Alone.

Access Better Coverage  |  From Our Network

To make matters worse, she discovered that the physical therapist she was seeing - at a cost of $300 per week - was out of network.

Medicines in Development for Vaccines

PhRMA  |  Press Release

(April 20, 2012)— America’s biopharmaceutical research companies are developing nearly 300 vaccines for the prevention and treatment of a wide variety of diseases, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

New Study Details Foreign Efforts To Lure Biopharmaceutical Companies

PhRMA  |  Press Release

The impact of the sector goes beyond jobs – over the last decade, biopharmaceutical companies have brought more than 300 new medicines to the patients who need them.

U.S. is Still Most Attractive Country for Biopharma Investment; BRICs, Canada Lag Behind

PhRMA  |  Press Release

The BCI, a global survey-based index of economies’ biomedical competiveness, polls 350 biopharmaceutical executives of top-ranking multinational companies operating in 16 economies – who serve as ambassadors to their companies of the investment attractiveness of each market.

Director - Communications

PhRMA  |  PhRMA Career

Connect with PhRMAFor information on how innovative medicines save lives, please visit: What we offerIn addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members.

Director – State Advocacy

PhRMA  |  PhRMA Career

Connect with PhRMA For information on how innovative medicines save lives, please visit: What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members.

New Report Shows Record Number of Medicines Currently in Development to Treat Mental Illness

PhRMA  |  Press Release

An estimated 300 million people worldwide – including 60 million Americans – struggle with mental health problems.

Know the Signs of Stroke and Act Quickly

PhRMA  |  Blog Post

May 15, 2003 came to be known as the Very Bad Day.

PhRMA Statement on PCAST Innovation Report

PhRMA  |  Press Release

“Over the last decade, the biopharmaceutical industry, oftentimes partnering with academia and federal research institutions, has brought more than 300 new medicines to patients and PhRMA companies alone have invested $500 billion in research and development of new therapies.

PhRMA Careers, Senior Director of Accounting

PhRMA  |  PhRMA Career

What we offer In addition to a highly competitive salary, generous 401(k) employer contribution, and platform of benefits (health, dental, vision, life and AD&D, short and long term disability, long term care, and Metro benefit), PhRMA is committed to the development and overall wellbeing of its staff.

Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals

PhRMA  |  Blog Post

Part of this mission hinges on the robust flow of the latest scientific information – information that should inform patient care.

PhRMA Statement on Healthcare Reform Coalition

PhRMA  |  Press Release

For example, non-adherence to prescribed medicines has been estimated to cost $100 billion-$300 billion annually, including costs from avoidable hospitalizations and nursing home admissions.

Sources of Adherence Research Funding

PhRMA  |  From PhRMA

  National Institute of HealthmHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R03)Deadline: September 7, 2014 This initiative seeks to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations.

Ask About Adherence: Q&A with PhRMA Foundation Young Investigator Adherence Grantee - Sujit S. Sansgiry

PhRMA  |  Blog Post

SANSGIRY: The cost of medication nonadherence has been estimated to be $100 billion to $300 billion annually for the U.S. health care system.

Patients: They're at the Table – It’s About Time to Ask Them What Should be Served

PhRMA  |  Blog Post

In just five days, more than 300 research questions were submitted.

Is Your Medicine Right For Your Metabolism?

From Hope To Cures  |  From Our Network

Researchers discovered that about 1 in 300 children being treated for childhood leukemia had a gene variation that made the drug thiopurine destroy their bone marrow.

Don’t lie down!

PhRMA  |  Blog Post

  At that moment, everyone was talking.

Medicare Monday: 4 Things You May Not Know about Competition in Part D

PhRMA  |  Blog Post

A recent study found that beneficiaries reduced their average annual out-of-pocket costs by almost $300 from 2006 to 2007 by switching to a new plan.

New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy

PhRMA  |  Press Release

This sector includes approximately 300 companies employing over 5,410 people with average salaries of $93,000 [a year].”

What They Aren’t Telling You About Medicine Prices

PhRMA  |  Blog Post

Any honest dialogue on costs needs to take into account the following facts:  Official government estimates show the cost of medicines will rise at about the same rate as overall health care spending through the next decade.

Research & Hope Awards

PhRMA  |  Press Release

To learn about the nearly 300 vaccines in development for both preventative and therapeutic uses, see PhRMA’s new Vaccines in Development report.

You have reviewed the first 425 results out of 430. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next